Supreme Court Says Generic-Drug Companies Shielded From Suits

Companies can't be sued for failing to warn about side effects, according to 5-4 ruling.

The U.S. Supreme Court ruled that generic-drug companies, unlike their brand-name rivals, can’t be sued for failing to warn patients about the risk of dangerous side effects.

The 5-4 ruling bars two women from suing units of Mylan Inc. and Teva Pharmaceutical Industries Ltd. over metoclopramide, a stomach drug they say caused them to contract a severe neurological disorder.

Copyright 2016 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Comments

Advertisement. Closing in 15 seconds.